Mostrar el registro sencillo

dc.contributor.authorBousquets-Muñoz, Pablo
dc.contributor.authorMolina, Oscar
dc.contributor.authorVarela Egocheaga, Ignacio 
dc.contributor.authorÁlvarez-Eguiluz, Ángel
dc.contributor.authorFernández-Mateos, Javier
dc.contributor.authorGómez, Ana
dc.contributor.authorSánchez, Elena G.
dc.contributor.authorBalbín, Milagros
dc.contributor.authorRuano, David
dc.contributor.authorRamírez-Orellana, Manuel
dc.contributor.authorPuente, Xose S.
dc.contributor.authorMenédez, Pablo
dc.contributor.authorVasco-Hernández, Talia
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2024-09-16T14:14:20Z
dc.date.available2024-09-16T14:14:20Z
dc.date.issued2024
dc.identifier.issn0887-6924
dc.identifier.issn1476-5551
dc.identifier.otherPID2022-142966OB-I00es_ES
dc.identifier.otherCPP2021-008508es_ES
dc.identifier.otherCPP2022-009759es_ES
dc.identifier.urihttps://hdl.handle.net/10902/33811
dc.description.sponsorshipACKNOWLEDGEMENTS: This research was partially supported by a donation from the patient’s family and Heroga Fertilizantes. Research in PM’s laboratory is supported by CERCA/Generalitat de Catalunya and Fundació Josep Carreras-Obra Social la Caixa for core support, the European Research Council grants (ERC-PoC-957466, ERC-PoC-101100665), the H2020 EU program (101057250-CANCERNA), the MINECO (PID2022-142966OB-I00/ MCIN/ AEI/10.13039/501100011033 and Feder Funds), the MINECO/European Union NextGenerationEU (CPP2021-008508, CPP2022-009759); the Deutsche José Carreras Leukämie-Stiftung (DJCLS15R/2021 and DJCLS 02R/2023), the Spanish Association Against Cancer (AECC, PRYGN234975MENE) and the ISCIII-RICORS within the Next Generation EU program (plan de Recuperación, Transformación y Resilencia). Research in XSP’s laboratory is supported by Ministerio de Ciencia e Innovación (PID2020-117185RB-I00); the Spanish Association Against Cancer (AECC); Centro de Investigación Biomédica en Red Cáncer (CIBERONC); “La Caixa” Foundation CLLSYSTEMS (HR22-00172), European Union NextGenerationEU/Mecanismo para la Recuperación y la Resilencia (MRR)/PRTR and the Instituto de Salud Carlos III (ISCIII) (PMP21/00015). OM and TV-H were supported by an investigator award from AECC (INVES211226MOLI and INVES223069VELA, respectively).es_ES
dc.format.extent5 p.es_ES
dc.language.isoenges_ES
dc.publisherNature Publishing Groupes_ES
dc.rights© The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourceLeukemia, 2024, 38, 1808-1812es_ES
dc.titleBacktracking NOM1:ETV6 fusion to neonatal pathogenesis of t(7;12) (q36;p13) infant AMLes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://doi.org/10.1038/s41375-024-02293-9es_ES
dc.rights.accessRightsopenAccesses_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/PID2022-142966OB-I00/ES/INESTABILIDAD CROMOSOMICA Y PATOFISIOLOGIA DE LAS CELULAS INICIADORAS DE LEUCEMIA EN LA LEUCEMIA LINFOBLASTICA AGUDA PEDIATRICA CON ANEUPLOIDIAS/es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/CPP2021-008508/ES/Desarrollo de una nueva terapia CAR-T dirigida a CD1a para el tratamiento de leucemias%2Flinfomas de células T CD1a+/es_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023/CPP2022-009759/ES/Desarrollo de una terapia CAR-T dual dirigida a CD1a%2FCCR9 para el tratamiento de la leucemia linfoblástica aguda de células T R%2FR/es_ES
dc.identifier.DOI10.1038/s41375-024-02293-9
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

© The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.Excepto si se señala otra cosa, la licencia del ítem se describe como © The Author(s) 2024. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.